Skip to main content
. Author manuscript; available in PMC: 2021 Jan 13.
Published in final edited form as: J Geriatr Oncol. 2019 Jun 4;11(3):523–528. doi: 10.1016/j.jgo.2019.05.021

Table 2.

Baseline geriatric assessment domains (N=28)a (Impairments defined in Appendix A)

Characteristics (N=28) N (%)b
Age at GA - Median (range) 77 (66–91)
 ≤76 years 15 (54)
 >76 years 13 (46)
Timing of CGA
 Immediately prior to ICI 15 (54)
 Immediately prior to chemotherapy but prior to ICI 13 (46)
ADL impairment
 No 7 (25)
 Yes 7 (25)
 Unknown 14 (50)
IADL impairment
 No 12 (43)
 Yes 12 (43)
 Unknown 4 (14)
Falls in the past year
 No 19 (68)
 Yes 9 (32)
SPPB impairment
 No 3 (11)
 Yes 21 (75)
 Unknown 4 (14)
Comorbidities
 ≤4 8 (28)
 >4 12 (43)
 Unknown 8 (28)
Hearing impairment
 No 16 (57)
 Yes 9 (32)
 Unknown 3 (11)
Vision impairment
 No 18 (64)
 Yes 7 (25)
 Unknown 3 (11)
BOMC Score impairment
 No 17 (61)
 Yes 10 (36)
 Unknown 1 (3)
Weight lossc
 No 12 (43)
 Yes 11 (39)
 Unknown 5 (18)
Sarcopenia (Patient-Reported)d
 No 10 (36)
 Yes 8 (28)
 Unknown 10 (36)
OARS social support impairment
 No 14 (50)
 Yes 9 (32)
 Unknown 5 (18)
GDS Score impairment
 No 21 (75)
 Yes 7 (25)
VES-13 scale impairment
 No 8 (28)
 Yes 13 (46)
 Unknown 7 (25)

Abbreviations: ADL, Activities of Daily Living; BOMC, BLESSED Orientation-Memory-Concentration Test; GA, geriatric assessment; IADL, Instrumental Activities of Daily Living; OARS, Older American Resources and Services; SPPB, Short Physical Performance Battery Test; VES-13, Vulnerable Elders Survey-13

a

Data expressed as N (%) unless otherwise specified.

b

Due to rounding, percentages may not always add up to 100%

c

Defined as more than 5%

d

Using the SARC-F questionnaire